Castrate-resistant prostate cancer cells that acquire a completely AR-independent phenotype, whether of neuroendocrine or non-neuroendocrine type, typically display a more aggressive phenotype with rapid disease progression [41, 42]. Here, AR is linked to prostate cancer.